Zhong Rui, Li Hui, Zhang Shuang, Liu Jingjing, Cheng Ying
Medical Oncology Translational Research Lab, Jilin Provincial Cancer Hospital, Changchun 130012, China.
Department of Toracic Oncology, Jilin Provincial Cancer Hospital, Changchun 130012, China.
Zhongguo Fei Ai Za Zhi. 2018 Sep 20;21(9):712-718. doi: 10.3779/j.issn.1009-3419.2018.09.11.
Tumor heterogeneity is one of the characteristics of malignant tumors, which can cause differences in tumor growth rate, invasion, migration, drug sensitivity and prognosis. Discoveries and development upon on tumor-driver genes and targeted therapy paved the way on dealing with cancer diagnosis and treatment. However, the existence of tumor heterogeneity makes malignant tumor more hardly to overcome. It is generally present and far more complicated during the process of cancer recurrence, development and evolution. Thus, it has becoming key areas in precision medicine regarding to designing optimal therapeutic approaches targeting the mechanisms and phenotypes of tumor heterogeneity, based on novel detecting techniques and new concepts and theory. This review summarized the current references on tumor heterogeneity, in order to better understand the function and mechanisms, and eventually manage tumor heterogeneity through various methods. .
肿瘤异质性是恶性肿瘤的特征之一,可导致肿瘤生长速度、侵袭、迁移、药物敏感性和预后的差异。肿瘤驱动基因和靶向治疗的发现与发展为癌症的诊断和治疗铺平了道路。然而,肿瘤异质性的存在使恶性肿瘤更难攻克。它普遍存在,并且在癌症复发、发展和演变过程中更为复杂。因此,基于新的检测技术、新的概念和理论,针对肿瘤异质性的机制和表型设计最佳治疗方法已成为精准医学的关键领域。这篇综述总结了当前关于肿瘤异质性的参考文献,以便更好地理解其功能和机制,并最终通过各种方法应对肿瘤异质性。